DCGO

DocGo Inc

Add to Watchlist

Advanced Chart

1.110

+0.04(3.738%)1D

Line

Candle

YTD

High

1.130

Open

1.070

VWAP

1.08

Vol

1.02M

Mkt Cap

108.57M

Low

1.050

Amount

1.10M

EV/EBITDA(TTM)

Total Shares

101.57M

41.84M

EV/OCF(TTM)

0.48

P/S(TTM)

0.26

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

78.65M

-18.1%

-0.050

-44.55%

71.83M

-40.55%

-0.124

+210.18%

69.16M

-50.13%

-0.134

-368.02%

Estimates Revision

The market is revising Upward the revenue expectations for DocGo Inc. (DCGO) for FY2025, with the revenue forecasts being adjusted by 0.07% over the past three months. During the same period, the stock price has changed by -29.30%.

Revenue Estimates for FY2025

Revise Upward

+0.07%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+14.86%

In Past 3 Month

Stock Price

Go Down

-29.30%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is 3.15 USD with a low forecast of 1.60 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

2 Hold

0 Sell

Moderate Buy

Current: 1.110

Low

1.60

Averages

3.15

High

4.00

Current: 1.110

Low

1.60

Averages

3.15

High

4.00

Canaccord

Richard Close

Hold

maintain

2025-08-21

Reason

Canaccord

Richard Close

Price Target

2025-08-21

maintain

Hold

Reason

Canaccord analyst Richard Close raised the firm's price target on DocGo to $1.60 from $1.45 and keeps a Hold rating on the shares. The firm said DocGo showed some progress with its core business in 2Q as it works to replace the waning migrant services contract(s) that should be largely wound down entering 2H;however, there is much work to be done to rightsize the organization while also ramping up new business.

Canaccord

Buy

Hold

downgrade

2025-05-12

Reason

Canaccord

Price Target

2025-05-12

downgrade

Buy

Hold

Reason

Northland

Outperform

downgrade

$6 -> $4

2025-05-12

Reason

Northland

Price Target

$6 -> $4

2025-05-12

downgrade

Outperform

Reason

BTIG

Buy -> Neutral

downgrade

2025-05-09

Reason

BTIG

Price Target

2025-05-09

downgrade

Buy -> Neutral

Reason

Stifel

David Grossman

Buy

downgrade

2025-05-09

Reason

Stifel

David Grossman

Price Target

2025-05-09

downgrade

Buy

Reason

Canaccord

Richard Close

Buy

Hold

downgrade

2025-05-09

Reason

Canaccord

Richard Close

Price Target

2025-05-09

downgrade

Buy

Hold

Reason

Canaccord analyst Richard Close downgraded DocGo to Hold from Buy with a price target of $1.45, down from $5.

See All Ratings

Valuation Metrics

The current forward P/E ratio for DocGo Inc (DCGO.O) is -3.22, compared to its 5-year average forward P/E of 34.82. For a more detailed relative valuation and DCF analysis to assess DocGo Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

34.82

Current PE

-3.22

Overvalued PE

73.65

Undervalued PE

-4.01

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

9.85

Current EV/EBITDA

-2.93

Overvalued EV/EBITDA

17.45

Undervalued EV/EBITDA

2.24

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.07

Current PS

1.11

Overvalued PS

1.68

Undervalued PS

0.45